| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/01/2006 | US20060116364 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer |
| 06/01/2006 | US20060116361 5-Amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 06/01/2006 | US20060116145 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 06/01/2006 | US20060115542 Therapeutic delivery of carbon monoxide |
| 06/01/2006 | US20060115538 Calcium lactate and whey permeate for lowering the triglyceride level |
| 06/01/2006 | US20060115500 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 06/01/2006 | CA2589468A1 Process for preparing novel crystalline forms of (2s)-1-[[(7r)-7-(3,4-dichlorophenyl)-4,7-dihydro-5-methylpyrazolo[1,5]pyrimidine-6-yl]carbonyl]-2-(4-fluorophenyl) pyrrolidine, novel stable forms produced therein and formulations |
| 06/01/2006 | CA2589460A1 New peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 06/01/2006 | CA2589439A1 Modulators of muscarinic receptors |
| 06/01/2006 | CA2589237A1 (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1,4homopiperazine hydrochloride dihydrate |
| 06/01/2006 | CA2586421A1 Pyridoxal-5-phosphate and stent for the treatment and prevention of atherosclerosis and restenosis |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1661913A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 05/31/2006 | EP1661909A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 05/31/2006 | EP1661907A1 A cardio myopeptidin, the production and the use thereof |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same |
| 05/31/2006 | EP1661879A1 Diphenyl ether compound, process for producing the same, and use |
| 05/31/2006 | EP1661581A1 Remedy for cardiac failure comprising ask1 inhibitor as the active ingredient and method of screening the same |
| 05/31/2006 | EP1661579A2 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 05/31/2006 | EP1661578A1 Skin ulcer preventive curative agent containing human recombinant hgf |
| 05/31/2006 | EP1661571A2 Medicaments for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660467A2 Aminofurazan compounds as protein kinase inhibitors |
| 05/31/2006 | EP1660183A2 Treating cardiovascular diseases with a compound of formula 1 (cs 747 - prasugrel; rn 150322-43-4) |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660089A1 Chemokine inhibiting piperazine derivatives and their use to treat myocarditis |
| 05/31/2006 | EP1660085A1 Pyridylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660076A1 Compositions and methods involving the combination of a thromboxane a2 receptor antagonist and an inhibitor of cyclooxigenase-1 |
| 05/31/2006 | EP1660066A1 Pharmaceutical composition comprising a combination of metformin and a statin |
| 05/31/2006 | EP1448181B1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1392295B1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1328282B1 Efficient method for producing compositions enriched in anthocyanins |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1296967B1 Benzothiazolyl ppar-gamma modulators |
| 05/31/2006 | EP1270570B1 Amide compounds and use thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1248641B1 Use of emap ii receptor antagonist composition for treating pulmonary hypertension |
| 05/31/2006 | EP1030651A4 Novel oral dosage form for carvedilol |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | CN1780838A Azabicyclononene derivatives |
| 05/31/2006 | CN1780820A Quinoxalinone-3- one derivatives as orexin receptor antagonists |
| 05/31/2006 | CN1780817A Aminocyclohexyl ether compounds and uses thereof |
| 05/31/2006 | CN1780816A 2-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 05/31/2006 | CN1780663A 9-azabicyclo nonylene derivatives with a heteroatom at the 3-position as renin inhibitors |
| 05/31/2006 | CN1780636A Combined use of G-CSF with angiogenetic factor |
| 05/31/2006 | CN1778820A Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 05/31/2006 | CN1778819A Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 05/31/2006 | CN1778386A Injection of troxerutin and encephalic protein hydrolysate |
| 05/31/2006 | CN1778377A Chinese medicine for treating hypertension emergency |
| 05/31/2006 | CN1778366A Medicine composition for hypertension and its preparation thereof |
| 05/31/2006 | CN1778356A Rehabilitation powder for paralysis |
| 05/31/2006 | CN1778354A Chinese medicine dropping ball for coronary heart disease and angina cordis |
| 05/31/2006 | CN1778353A Chinese medicine dropping ball for treating cardiovascular disease |
| 05/31/2006 | CN1778352A Chinese medicine composition for treating cardiovascular disease |
| 05/31/2006 | CN1778348A Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 05/31/2006 | CN1778347A Chinese medicine dropping ball for treating coronary heart disease |
| 05/31/2006 | CN1778346A Medicine for treating coronary heart disease |
| 05/31/2006 | CN1778345A Chinese medicine dropping ball for treating coronary heart disease |
| 05/31/2006 | CN1778344A Medicine for treating coronary heart disease |
| 05/31/2006 | CN1778343A Medicine dropping ball for treating coronary heart disease |
| 05/31/2006 | CN1778342A Chinese medicine composition for treating coronary heart disease |
| 05/31/2006 | CN1778341A Medicine dropping ball for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778340A Chinese medicine composition for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778339A Medicine dropping ball for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778338A Chinese medicine composition for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778337A Preparation of compound Danshen Root tablet |
| 05/31/2006 | CN1778336A Preparation of compound Danshen Root dropping ball |
| 05/31/2006 | CN1778335A Chinese medicine for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778334A Chinese Medicine dropping ball for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778333A Chinese medicine for treating coronary heart disease and angina cordis |
| 05/31/2006 | CN1778331A Compound injection from ice tablet and Danshen Root extract and its preparation thereof |
| 05/31/2006 | CN1778330A Compound Danshen Root slow-releasing tablet and its preparation thereof |
| 05/31/2006 | CN1778328A Polysatrifo Chinese medicinal oral preparation and its making method |
| 05/31/2006 | CN1778327A Medicine dropping ball for treating cardiovascular disease |
| 05/31/2006 | CN1778326A Medicine for treating cardiovascular disease |
| 05/31/2006 | CN1778323A Medicinal dropping ball for treating cardiovascular disease |
| 05/31/2006 | CN1778322A Chinese medicine for treating cardiovascular disease |
| 05/31/2006 | CN1778320A Compound injection from Chunxiongqin and Sanchi general saponin and its preparation |
| 05/31/2006 | CN1778319A Compound oral liquid from ice tablet and Sanchi general saponin and its preparation |
| 05/31/2006 | CN1778318A Compound injection from ice tablet and ginkgo leaf extract and its making method thereof |
| 05/31/2006 | CN1778303A Use of rhizoma anemarrhenae total saponin in preparation of medicine for treating hyperlipemia and arterial sclerosis |
| 05/31/2006 | CN1778302A 2-glucoside Chinese medicinal oral preparation and its making method thereof |
| 05/31/2006 | CN1778293A Rutin effervesce agent composition |
| 05/31/2006 | CN1778200A Composition with blue aeterio, grape seed, ginkgo leaf, Danshen root and chuanxiong |
| 05/31/2006 | CN1257914C Process for extracting oleanolic acid-3-O-beta-D pyrane glucuronide from general aralia chinensis saponin and its usage |
| 05/31/2006 | CN1257908C Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 05/31/2006 | CN1257907C Ginkgo lactone compound and its preparation and medicinal composition containing it |
| 05/31/2006 | CN1257906C Preparation process of isosorbide mononitrate |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257893C PPAR full activator of amino acids of aralkyl possessing excellent activity for lowering sugar and ester |
| 05/31/2006 | CN1257735C Medicine for treating heart function insufficieny and preparing method thereof |